- Align Technology Inc (ALGN): 8.11%
- Eli Lilly and Co (LLY): 7.00%
- Chugai Pharmaceutical Co Ltd (4519.T): 5.20%
- Regeneron Pharmaceuticals Inc (REGN): 5.01%
- Novo Nordisk AS ADR (NVO): 4.66%
- AbbVie Inc (ABBV): 4.50%
- Johnson & Johnson (JNJ): 4.48%
- Biohaven Ltd (BHVN): 4.13%
- Jazz Pharmaceuticals PLC (JAZZ): 3.92%
- Amgen Inc (AMGN): 3.88%
PINK ETF — Holdings & Analysis
Simplify Health Care ETF (PINK) is an equity ETF with $0.25B in assets under management and an expense ratio of 0.51%. PINK focuses on multi-cap exposure to innovative companies within the healthcare sector, including biotech, medtech, and gene therapy.
A key differentiator is its 100% pro bono structure, with net profits donated to the Susan G. Komen foundation annually, making it a unique investment option for those seeking both financial returns and social impact.
Simplify Health Care ETF (PINK) ETF — Price, Holdings & Analysis
Simplify Health Care ETF (PINK) is an equity ETF with $0.25B in assets under management and an expense ratio of 0.51%. PINK focuses on multi-cap exposure to innovative companies within the healthcare sector, including biotech, medtech, and gene therapy. A key differentiator is its 100% pro bono structure, with net profits donated to the Susan G. Komen foundation annually, making it a unique investment option for those seeking both financial returns and social impact.
Visão Geral do ETF
Simplify Health Care ETF (PINK) seeks long term capital appreciation by providing investors with multi-cap exposure to groundbreaking and innovative companies in biotech, medtech, gene therapy, and other fast growing health care related sectors. Michael Taylor serves as lead portfolio manager of the ETF and brings over two decades of experience managing long/short health care equity portfolios at leading hedge funds. PINK is the first 100% pro bono ETF focused on the health care sector and net profits will be donated for the benefit of the Susan G. Komen foundation on an annual basis. PINK: Shares for the Cure Find out more. Benefiting Donations$350,000as of 09/01/25
Simplify Health Care ETF (PINK) aims for long-term capital appreciation by investing in a diverse range of healthcare companies. The fund provides multi-cap exposure to groundbreaking and innovative companies in the biotech, medtech, gene therapy, and other fast-growing healthcare-related sectors. PINK's portfolio is actively managed by Michael Taylor, who brings over two decades of experience managing long/short healthcare equity portfolios. The fund's top holdings include Align Technology Inc (8.11%), Eli Lilly and Co (7.00%), and Chugai Pharmaceutical Co Ltd (5.20%). With a significant allocation to the healthcare sector (95.0%), the fund offers targeted exposure to this industry. The remaining 5.0% is allocated to industrials. PINK distinguishes itself as the first 100% pro bono ETF focused on the healthcare sector, donating net profits to the Susan G. Komen foundation annually.
Métricas de Risco
Investing in the Simplify Health Care ETF (PINK) involves certain risks. With 95.0% of its assets allocated to the healthcare sector, PINK exhibits significant sector concentration risk, making it vulnerable to industry-specific downturns. The fund's beta of 0.87 indicates that it is theoretically less volatile than the broader market. The expense ratio of 0.51% will create a drag on performance over time. Country exposure is primarily concentrated in the United States (81.4%), which could expose the fund to risks associated with the U.S. economy and regulatory environment. their may be worth researching risk tolerance and investment objectives before investing in PINK. Past performance does not guarantee future results.
Taxa de Despesa
0.51%
Principais Posições
Como o fundo está alocado?
- Saúde: 95.0%
- Industriais: 5.0%
- Estados Unidos: 81.4%
- Dinamarca: 6.7%
- Japão: 5.3%
- Irlanda: 4.0%
- Reino Unido: 2.1%
- Outros: 0.5%
- França: 0.0%
Dividend Yield
0.00%
- State Street Technology Select Sector SPDR ETF (XLK) — 0.08% de taxa de despesas
- State Street Financial Select Sector SPDR ETF (XLF) — 0.08% de taxa de despesas
- State Street Energy Select Sector SPDR ETF (XLE) — 0.08% de taxa de despesas
- Invesco QQQ Trust, Series 1 (QQQ) — 0.18% de taxa de despesas
- iShares Russell 2000 ETF (IWM) — 0.19% de taxa de despesas
- iShares MSCI EAFE ETF (EFA) — 0.32% de taxa de despesas
- State Street SPDR S&P 500 ETF (SPY) — 0.09% de taxa de despesas
- iShares MSCI Emerging Markets ETF (EEM) — 0.72% de taxa de despesas
- Simplify Propel Opportunities ETF (SURI) (Ações) — 2.82% de taxa de despesas
- Simplify Currency Strategy ETF (FOXY) (Alternativos) — 0.81% de taxa de despesas
- Simplify Bitcoin Strategy PLUS Income ETF (MAXI) (Alternativos) — 1.00% de taxa de despesas
- Simplify Aggregate Bond ETF (AGGH) (Renda fixa) — 0.55% de taxa de despesas
- Simplify DBi CTA Managed Futures Index ETF (SDMF) (Alternativos) — 0.35% de taxa de despesas
- Simplify Government Money Market ETF (SBIL) (Renda fixa) — 0.15% de taxa de despesas
Métricas de Risco
- Beta: 0.87
Perguntas e Respostas
What is PINK and what does it track?
Simplify Health Care ETF (PINK) is an equity ETF that seeks long-term capital appreciation by investing in groundbreaking and innovative companies within the healthcare sector. This includes companies involved in biotech, medtech, gene therapy, and other fast-growing healthcare-related areas. PINK stands out as the first 100% pro bono ETF focused on the healthcare sector, donating its net profits annually to the Susan G. Komen foundation. The fund's portfolio is actively managed and includes a diverse range of healthcare companies, aiming to capture growth opportunities within the industry.
What is the expense ratio for PINK?
Simplify Health Care ETF (PINK) has an expense ratio of 0.51%. This means that for every $10,000 invested, $51 is used to cover the fund's operating expenses annually. While this is higher than some broad market ETFs, it is important to consider the specialized focus of PINK on innovative healthcare companies. When evaluating the expense ratio, the may be worth researching potential returns and the unique philanthropic aspect of the fund, which donates net profits to the Susan G. Komen foundation.
What are the top holdings in PINK?
Simplify Health Care ETF (PINK) has a concentrated portfolio of healthcare companies. As of 2026-03-15, the top holdings include Align Technology Inc (8.11%), Eli Lilly and Co (7.00%), and Chugai Pharmaceutical Co Ltd (5.20%). Regeneron Pharmaceuticals Inc (5.01%) and Novo Nordisk AS ADR (4.66%) also represent significant portions of the fund's assets. These companies reflect PINK's focus on innovative and growth-oriented businesses within the healthcare sector.
Is PINK a good long-term investment?
Determining whether the Simplify Health Care ETF (PINK) is a suitable long-term investment depends on individual investment goals and risk tolerance. PINK focuses on the healthcare sector, specifically innovative companies in biotech, medtech, and gene therapy. The fund has an expense ratio of 0.51% and a beta of 0.87. Its unique pro bono structure, donating net profits to the Susan G. Komen foundation, may appeal to socially conscious investors. Past performance does not guarantee future results.
How does PINK compare to similar ETFs?
Simplify Health Care ETF (PINK) distinguishes itself from other healthcare ETFs primarily through its philanthropic mission, donating net profits to the Susan G. Komen foundation. In terms of expense, PINK's expense ratio is 0.51%. While some healthcare ETFs may have lower expense ratios, PINK's unique structure and active management may justify the cost for some investors. With AUM of $0.25B, PINK is smaller than some of the more established healthcare ETFs. Investors should weigh these factors when comparing PINK to its peers.
Does PINK pay dividends?
As of 2026-03-15, the Simplify Health Care ETF (PINK) has a dividend yield of 0.00%. This indicates that the fund does not currently distribute dividends to its shareholders. PINK's investment strategy focuses on capital appreciation through investments in growth-oriented healthcare companies rather than generating income through dividends. Investors seeking dividend income may need to consider alternative investment options.